Shandong Pharmaceutical GlassLtd Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jun Zhang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5.7yrs |
| CEO ownership | n/a |
| Management average tenure | 5.7yrs |
| Board average tenure | 3.7yrs |
Recent management updates
Recent updates
There Is A Reason Shandong Pharmaceutical Glass Co.Ltd's (SHSE:600529) Price Is Undemanding
Dec 13
Returns On Capital At Shandong Pharmaceutical GlassLtd (SHSE:600529) Have Hit The Brakes
Aug 25Calculating The Fair Value Of Shandong Pharmaceutical Glass Co.Ltd (SHSE:600529)
May 31The Returns At Shandong Pharmaceutical GlassLtd (SHSE:600529) Aren't Growing
May 13Shandong Pharmaceutical Glass Co.Ltd Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next
Apr 26CEO
Jun Zhang (55 yo)
5.7yrs
Tenure
CN¥1,761,000
Compensation
Mr. Jun Zhang has been a General Manager of Shandong Pharmaceutical Glass Co., Ltd since May 13, 2019 and served its Deputy General Manager since May 11, 2013. Mr. Zhang was workshop Manager for Shandong P...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Deputy GM & Director | 5.7yrs | CN¥1.06m | no data | |
| Deputy GM & Director | 5.7yrs | CN¥1.07m | no data | |
| Deputy General Manager | no data | CN¥1.00m | no data | |
| Deputy General Manager | no data | CN¥781.00k | no data | |
| Deputy General Manager | no data | CN¥751.00k | no data | |
| GM & Director | 5.7yrs | CN¥1.76m | no data | |
| Chief Financial Officer | 11.7yrs | CN¥609.00k | no data |
5.7yrs
Average Tenure
52yo
Average Age
Experienced Management: 600529's management team is seasoned and experienced (5.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Deputy GM & Director | 11.7yrs | CN¥1.06m | no data | |
| Deputy GM & Director | 11.7yrs | CN¥1.07m | no data | |
| GM & Director | 11.7yrs | CN¥1.76m | no data | |
| Chairman of the Supervisory Board | 2.7yrs | CN¥1.86m | 0.0015% CN¥ 270.4k | |
| Chairman | 11.7yrs | CN¥1.44m | 0.0089% CN¥ 1.6m | |
| Supervisor | 11.7yrs | no data | no data | |
| Independent Director | 3.7yrs | CN¥100.00k | no data | |
| Independent Director | 3.7yrs | CN¥100.00k | no data | |
| Outside Independent Director | 1.1yrs | no data | no data | |
| Outside Independent Director | 1.1yrs | no data | no data | |
| Independent Director | 1.1yrs | no data | no data |
3.7yrs
Average Tenure
52yo
Average Age
Experienced Board: 600529's board of directors are considered experienced (3.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 03:15 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shandong Pharmaceutical Glass Co.Ltd is covered by 20 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yin Zhang | BOCI Research Ltd. |
| Chao Fan | Changjiang Securities Co. LTD. |
| Liang Long | Chasing Securities |